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Decreased Systolic Function and Inadequate Hypertrophy in Large
and Small Breed Dogs with Chronic Mitral Valve Insufficiency
Michele Borgarelli, Alberto Tarducci, Renato Zanatta, and Jens Haggstrom
Background: Systolic dysfunction associated with chronic mitral valve insufficiency (CMVI) has been demonstrated in
experimental animal models and large breed (LB) dogs but has been reported as an uncommon finding in small breed (SB)
dogs with naturally occurring disease. It has been suggested the myocardial failure could be, in part, because of an insufficient
increase in left ventricular mass.
Hypothesis: To test if SB and LB dogs with CMVI and moderate heart failure have systolic dysfunction and if they have
adequate eccentric hypertrophy.
Animals: Data from 38 SB and 18 LB dogs affected with CMVI were compared retrospectively with results from 2 groups of
normal dogs (17 SB and 32 LB)
Methods: Systolic function was investigated echocardiographically by using percentage fractional shortening (FS), the ratio
between observed and expected end-systolic diameter (ESD/ESDe), and end-systolic volume index (ESVI). Left ventricular
hypertrophy was estimated by using the ratio between the thickness of the left ventricular free wall and the radius in diastole
(h/R).
Results: Both affected SB and LB dogs had a significantly increased FS and ESVI (FS% SB 45.6 + 8.04 versus 40.06 + 8.9, P
, .05; FS% LB 33.64 + 8.61 versus 27.3 + 7.3 P , .05; ESVI SB 30.0 6 2.3 mL/m2 versus 21.18 6 13.9 mL/m2, P , .05; ESVI
LB 83.22 6 43.84 mL/m2 versus 36.43 6 13.30 mL/m2 versus P , .001). The h/R in affected animals was decreased (0.53 6
0.11 versus 0.416 0.12, P , .05 SB; 0.47 6 0.11 versus 0.38 6 0.09, P , .05, LB).
Conclusions and Clinical Importance: Data from this study indicate that dogs with moderate heart failure caused by CMVI
have systolic dysfunction. Inadequate hypertrophy of the left ventricle may be, in part, responsible for this finding.
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C hronic mitral valve insufficiency (CMVI), causedby myxomatous degeneration of the valve, is the
most common acquired heart disease in dogs. Systolic
dysfunction has been reported as an uncommon finding
in affected small breed (SB) dogs, and, if present, it has
been considered an end-stage finding in CMVI or the
effect of complicating factors, such as multiple small
intramural myocardial infarcts.1–3 Studies of experimen-
tally induced chronic mitral regurgitation in dogs
suggest that an inadequate degree of ventricular
hypertrophy develops in this condition and could be
one mechanism that contributes to the left ventricular
dysfunction observed both in people and in experimental
dogs.4,5 Wall stress imposed by pure volume overload
has been hypothesized to be an insufficient stimulus for
myocardial hypertrophy and in a large breed (LB)
canine experimental model of CMVI this condition was
associated with inadequate left ventricular hypertrophy,
culminating in systolic dysfunction.5 Patients with
CMVI have reduced afterload, because blood is re-
gurgitated in the left atrium, which is a relatively low-
pressure chamber. Because increased afterload is one of
the stimuli for hypertrophy represented by increased
afterload, pure volume overload is an insufficient
stimulus for hypertrophy.
Echocardiography is a useful tool for noninvasive
evaluation of systolic function.6,7 However, most of the
indices commonly used to evaluate systolic function,
such as fractional shortening (FS), ejection fraction
(EF), end-systolic volume index (ESVI), are strictly
dependent on intrinsic contractility, preload, afterload,
and wall stress. Therefore, any variation in these indices
must take into account these factors. Other variables
that can influence the echocardiographic evaluation of
systolic function include age; sex; weight; breed;
comorbid factors, eg, hypothyroidism; and hydration
status. In dogs, weight and breed especially appear to be
important variables influencing echocardiographic mea-
surements.8–11 FS and EF estimated by M-mode
measurements decrease with increasing body weight
(BW) and generally in LB dogs.8,12 ESVI has been
proposed as a more accurate parameter of systolic
dysfunction, because it is mainly dependent on afterload
and contractility, and is relatively independent of
preload.13 Values .30 mL/m2 are considered to indicate
systolic dysfunction.3,13 However, although ESVI repre-
sents a volume index, it is calculated by using the
Teicholz formula14 from an M-mode linear measure-
ment, which means that it may also be influenced by BW
and breed. Furthermore, any error in M-mode linear
measurement is raised to the power of 3 according to the
formula used to calculate ESVI.
In a previous study, we demonstrated that LB dogs
affected with mitral valve insufficiency more commonly
have moderate-to-severe systolic dysfunction compared
with SB dogs.15,16 This difference could be because of
decreased contractility in LB dogs compared with SB
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dogs, or because LB dogs have different normal systolic
values, which means that systolic function could be
over- or underestimated in both groups. To test this
hypothesis, we compared systolic function by using
echocardiography in LB and SB dogs affected with
CMVI with those of 2 groups of normal dogs.
Moreover, to test if systolic dysfunction could be
a consequence of inadequate hypertrophy, we also
evaluated the degree of left ventricle eccentric hypertro-
phy in LB and SB dogs with CMVI.
Material and Methods
Study Design
The medical records of dogs examined at the Small Animal
Hospital of the Faculty of Veterinary Medicine of Torino between
January 2000 and October 2004 were reviewed. From these records,
38 consecutive dogs weighing .20 kg (LB group) and 18
consecutive dogs weighing ,15 kg (SB group) affected by mitral
valve disease were selected. All dogs were presented for cardiology
consultation because of previous identification of a heart murmur
or because of the presence of clinical signs indicating a cardiovas-
cular disorder (eg, cough, exercise intolerance). Forty-nine normal
dogs were examined prospectively during the period from
September 2003 to October 2004. The dogs were divided into 2
groups according to their BW: normal SB dogs (NSB) who weighed
,15 kg (n 5 17) and normal LB dogs (NLB) who weighed .20 kg
(n 5 32). All dogs had been presented for annual physical
examinations. Dogs were considered normal based on the absence
of clinical signs of heart disease, normal systolic blood pressure
(SBP), and the absence of echocardiographic abnormalities. The 8
Doberman Pinchers and the 3 Great Danes included in LB group
were part of a screening program for dilated cardiomyopathy and
did not have any echocardiographic evidence of increased left
ventricular dimensions or arrhythmias on 2-minute ECG record-
ings, in the past 2 years on at least 2 screening echocardiographic
examinations.
Inclusion Criteria. Affected dogs were those with recognition of
mitral valve prolapse (MVP); any degree of mitral valve leaflet
thickening by 2-dimensional (2-D) echocardiography or the
identification of any degree of mitral valve regurgitation, with or
without mitral valve lesions by color-Doppler examination. To be
included in the analysis, dogs must have had at least one of these
abnormalities. Left ventricular FS had to be .20%, and left
ventricular ejection fraction (EF) had to be .40%. Left atrium
aortic root ratio (LA/Ao), evaluated by using the B-mode method,
had to be .1.7. Dogs must have been presented with signs of heart
failure (eg, exercise intolerance, dyspnea, cough) and have had
documented past evidence of pulmonary edema on thoracic
radiographs for at least 3 months. Thus, each included dog was
classified as class II heart failure according to International Small
Animal Health Cardiac Council (ISACHC) recommendations.17
All affected dogs were on therapy with benazepril (0.5 mg/kg PO
q24h) or enalapril (0.5 mg/kg PO q12h) and furosemide (mean
dosage 1.85 mg/kg PO q12h; range, 0.8–2.5 mg/kg PO q12h) at
least for 3 months.
Exclusion Criteria. Exclusion criteria included the presence of
systemic hypertension, congenital heart diseases, or acquired
cardiovascular disorders that primarily or secondarily affect the
mitral valve (eg, bacterial endocarditis, dilated cardiomyopathy).
Blood pressure was measured noninvasively by Doppler sphygmo-
manometry,a and hypertension was defined as systolic arterial
blood pressure (SBP) .180 mm Hg.18 Mitral endocarditis was
excluded based on clinical findings, CBC, and serum biochemistry,
and the lack of large vegetative lesions, with a heterogeneous
appearance on echocardiography.19 Dilated cardiomyopathy was
excluded based on the presence of valve changes consistent with
myxomatous mitral valve disease and MVP and the absence of
echocardiographic criteria such as FS , 20%, and left ventricular
EF ,40%.
Echocardiography. All dogs underwent complete echocardio-
graphic examination, which included transthoracic 2-D, M-mode,
spectral and color flow Doppler studies. Transducer arrays of 2.5–
3.5 MHz (LB and NLB group) and 3.5–5.0 MHz (SB and NSB
group) were used.b Examinations were performed in conscious,
unsedated dogs. Right parasternal M-mode recordings were
obtained from short-axis views with the dogs positioned in right
lateral recumbency, and the 2-D echocardiograms were obtained in
accordance with techniques described elsewhere.20,21
The presence of MVP and mitral valve thickening was evaluated
from the right parasternal long-axis view, the right parasternal 4-
chamber view,22,23 and left apical 4-chamber view.24 MVP was defined
as any systolic displacement of one or both mitral valve leaflets basal
to the mitral annulus, observed at least in two of these views.15
Mitral valve regurgitation was evaluated by using color Doppler
from the right parasternal long-axis view and left apical view, and
its severity was subjectively assessed by using the left apical 4-
chamber view as described below.
Echocardiographic Measurements
All echocardiographic measurements were made by 2 investi-
gators (MB, AT) and were reviewed by 1 investigator (MB) who
examined the videotape recordings. A mean of 3 consecutive
measurements in dogs with sinus rhythm, and 5 consecutive
measurements in dogs with atrial fibrillation (AF) was used for
each measurement. M-mode measurements were obtained accord-
ing to the leading-edge-to-leading-edge method.25 These included
left ventricular free-wall thickness in diastole (h), left ventricular
end-diastolic diameter (EDD) and end-systolic diameter (ESD).
Left ventricular radius (R) was obtained by dividing EDD by 2. FS
was calculated by using the following formula: [(EDD 2 ESD)/
EDD) 3 100]. Based on BW, the expected values for EDD and
ESD were calculated, according to Cornell et al11 by using the
formulas: EDDe 5 1.53 3 BW0.294 and ESDe 5 0.95 3 BW0.315.
The ratio between observed and expected values of EDD and EDS
were calculated (EDD/EDDe; ESD/ESDe) to allow comparisons
between groups of dogs with different body size. The end-diastolic
volume (EDV) and end-systolic volume (ESV) were calculated by
using the Teicholz method: EDV 5 [7 3 (EDD)3] /(2.4 + EDD) and
ESV 5 [7 3 (ESD)3]/(2.4 + ESD),14 and values were successively
indexed for body surface area to obtain the end-diastolic volume
index (EDVI) and the ESVI. The h/R ratio was used as a parameter
of left ventricular hypertrophy.26 Data were compared in dogs of
similar size.
Statistical Analysis
Statistical analysis was performed by using a commercial
statistical package (Instat 306).c Normally distributed data were
identified by using the Shapiro Wilk normality test. Within the 2
groups of normal dogs, the mean difference for observed EDD and
ESD and expected values was examined by using a paired Student’s
t-test. Among the 4 groups of dogs, the mean differences for each
of the studied variables were examined by using a unpaired
Student’s t-test. The chi-square test was used to compare
proportions between sexes. Equality of variances was assessed by
the F-test. Differences were considered significant if P , .05. Data
are reported as mean 6 standard deviation.
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Results
Normal Dogs
The NSB group included 17 dogs (5 males, 12
females): 5 mongrels; 4 Yorkshire Terriers; 2 Shi-Tzu; 2
English Cocker Spaniels; 1 each Dachshund, Jack
Russell Terrier, French Bulldog, and Pomeranian.
The mean age was 8.7 6 3.5 years (range, 1–14 years),
and the mean weight was 7.3 6 3.1 kg (range, 3.5–
13 kg). The NLB group included 32 dogs (17 males, 15
females): 8 Dobermann Pinchers; 6 German Shepherds;
5 mongrels; 3 Boxers; 3 Great Danes; 2 Rottweilers; 1
each Bulldog, Alaskan Malamute, Labrador Retriever,
Collie, and Golden Retriever;. The mean age was 5.3 +
3.7 years (range, 1–9 years), mean weight was 36.9 +
13.00 kg (range, 21–67 kg). Normal SB dogs were
significantly older (P , .05). There were no significant
differences by sex between the 2 groups (P 5 .19). SBP
was significantly higher in NSB (Table 1). All dogs
were judged to have a normal body condition scores.
The M-mode derived variables of left ventricular
function in the 2 groups are summarized in Table 1.
Normal SB dogs had higher FS and EF, and lower
ESVI compared with NLB dogs. No significant
difference in EDVI was found between the 2 groups.
The observed EDD (2.60 6 0.47 cm) and ESD (1.52 6
0.48 cm) were not significantly different compared with
expected values (EDDe 5 2.63 6 0.32 cm, P 5 .73;
ESDe 5 1.7 6 0.22 cm, P 5 .07) in NSB; whereas,
observed EDD (2.60 6 0.47 cm) was significantly
smaller and ESD was significantly larger (3.04 6 0.46
cm) compared with expected values (EDDe 5 4.67 6
0.29 cm, P , .001; ESDe 5 2.69 6 0.15 cm, P , .001)
in NLB. However, in NLB, both EDD and ESD values
were within 95% confidence intervals of the expected
values. The h/R ratio was similar in both groups.
Results of Normal Dogs Versus Dogs with CMVI
The SB dogs with CMVI included 6 mongrels, 4
Yorkshire Terriers, 3 Dachshunds, 3 Miniature Poo-
dles, 1 Epanieul Breton, and 1 Miniature Pincher. The
group consisted of 16 males and 2 females. The mean
weight was 11 6 2.7 kg (range, 3–15 kg), and the mean
age was 11 6 3.2 years (range, 9–14 years). The LB
dogs with CMVI (29 males, 9 females) included 28
German Shepherds, 5 Maremmano Shepherds, 2
mongrels, 1 Saluki, 1 Doberman Pincher, and 1
Dalmatian. The mean weight was 34.7 6 7.4 kg (range,
21–40 kg) and the mean age was 9.5 6 3.4 years (range,
8–15 years). Both SB and LB dogs with CMVI were
significantly older compared with the normal dogs (P ,
.05) and had a significantly lower SBP (P , .05). All
affected dogs had normal body condition scores. FS,
EDD/EDDe, ESD/ESDe, ESVI, and EDVI were
significantly higher in affected SB and LB dogs
compared with normal dogs of similar size (Tables 2
and 3). The h/R in affected animals was decreased
compared with normal groups (P , .05).
Discussion
The effect of pure volume overload secondary to
CMVI on left ventricular function is controversial.
Although many studies have identified normal left
ventricular function, others found a reduction.4,13,27–29
The discrepancies observed among these studies may be
related to the duration of volume overload, amount of
hypertrophy produced, or the type of experimental
volume overload examined. Data from our study
suggest that both SB and LB affected with CMVI and
moderate HF have some degree of systolic dysfunction.
Myocardial failure (MF) has been reported as an
uncommon finding in SB dogs affected by CMVI,
Table 1. M-mode echocardiographic parameters of left ventricular function in normal small and large breed dogs.*
SB Group (n 5 17) LB Group (n 5 32) P Value
Dog weight (kg) 7.3 6 3.1 36.9 6 13.00 ,.001
SBP (mm Hg) 159.25 6 12.8 141.0 6 17.4 ,.05
EDD (cm) 2.60 6 0.47 4.37 6 0.50 ,.001
EDDe (cm) 2.63 6 0.32 4.67 6 0.29 ,.001
ESD (cm) 1.52 6 0.48 3.04 6 0.46 ,.001
ESDe (cm) 1.70 6 0.22 2.69 6 0.15 ,.001
EDD/EDDe 0.99 6 0.13 0.94 6 0.10 ,.001
ESD/ESDe 0.89 6 0.21 1.13 6 0.15 ,.001
FS (%) 40.06 6 8.9 27 6 7.3 ,.001
EF (%) 70.75 6 9.20 56.85 6 10.2 ,.05
ESVI (mL/m2) 21.18 6 13.90 36.43 6 13.30 ,.001
EDVI (mL/m2) 70.5 6 26.5 84.10 6 20.21 NS
LA/Ao 1.22 6 0.31 1.27 6 0.20 NS
h/R 0.53 6 0.11 0.47 6 0.11 NS
SB, small breed; LB, large breed; SBP, systolic blood pressure; EDD, end diastolic diameter; ESD, end-systolic diameter; EDDe, expected
end diastolic diameter; ESDe, expected end-systolic diameter; FS, fractional shortening; EF, ejection fraction; ESVI, end-systolic volume
index; EDVI, end diastolic volume index; LA/Ao, left atrium aortic root ratio; h/R, left ventricular free-wall thickness/left ventricle diastolic
radius ratio; NS, not significant.
* Data are expressed as mean values 6 standard deviation.
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whereas it has been reported to be more common in LB
dogs2,15,16,30 and humans.31–33 In a previous study, we
compared systolic function in SB and LB dogs with
mitral valve disease showing that LB had decreased
systolic function compared with SB when using pre-
viously reported reference ranges.15,16 Body weight and
size are 2 of the factors that could influence some of the
echocardiographic measurements most commonly used
for evaluation of systolic function such FS and ESVI.8,11
Therefore, our previous results could have been influ-
enced by the different size of the 2 groups of dogs
studied. The current study shows that NSB had
significantly higher FS, EF, and lower ESVI compared
with NLB dogs, whereas EDVI was not different
between the 2 groups. To compensate for differences
in BW, we calculated expected EDD and ESD, as
described by Cornell et al11 and found no differences
among NSB. In LB dogs, although mean observed
values were different from the mean expected, they were
within the 95% reference interval for expected values for
that particular BW. ESVI was lower in SB dogs and
higher in LB to what it is commonly reported in the
normal reference values,3,34 and this finding is further
supported by the finding that the observed values were
similar to those expected in normal dogs. These
differences could be because of a different contractility
pattern. Indices of systolic function, such as the FS, EF,
and ESVI, are obtained often by using M-mode short-
axis measurements of the LV, but they assume a uniform
systolic contraction in all planes, which may not be true.
Therefore, B-mode estimation of the EF, such as the
area-length method, could more accurately measure
global systolic function, measuring contractility both on
the short and long axis. Indeed, we observed that EF
calculated by the area-length method did not differ
between the 2 groups of normal SB and LB dogs,
suggesting that LB dogs have systolic function more
prominently directed on the long axis.d The observation
that EDVI was similar in the 2 groups and that SBP was
significantly lower in the LB group, further supports our
hypothesis of a different pattern of ventricular contrac-
tion. In fact, this situation would lead to a smaller ESV.
Eccentric hypertrophy leading to an increase in short-
axis diameter would increase meridional stress, and
patients with a contractility pattern directed mainly
along the long axis, as may occur in LB dogs, may
Table 3. Echocardiographic parameters of left ventricular function in large breed normal dogs and dogs affected
with mitral valve disease. Data are expressed as mean values 6 standard deviation.
Normal LB (n 5 32) Affected LB (n 5 38) P Value
Dog weight (kg) 36.9 6 13.00 34.71 6 7.42 NS
Age (years) 5.3 6 3.7 9.5 6 3.4 ,.001
FS (%) 27.3 6 7.3 33.64 6 8.61 ,.05
EDD/EDDe 0.94 6 0.10 1.30 6 0.17 ,.001
ESD/ESDe 1.13 6 0.15 1.30 6 0.27 ,.001
ESVI (ml/m2) 36.43 6 13.30 83.22 6 43.84 ,.001
EDVI (ml/m2) 84.10 6 20.21 133.80 6 50.75 ,.05
LA/Ao 1.27 6 0.20 2.20 6 0.31 ,.001
h (cm) 1.05 6 0.18 1.02 6 0.17 NS
R (cm) 2.27 6 0.38 2.72 6 0.47 ,.05
h/R 0.47 6 0.11 0.38 6 0.09 ,.05
LB, small breed; NS, not significant; SBP, systolic blood pressure; FS, fractional shortening; EDD, end diastolic diameter; ESD, end
systolic diameter; EDDe, expected end diastolic diameter; ESDe, expected end systolic diameter; ESVI, end-systolic volume index; EDVI,
end diastolic volume index; LA/Ao, left atrium aortic root ratio; h/R, left ventricular free-wall thickness/left ventricle diastolic radius ratio.
Table 2. Echocardiographic parameters of left ventricular function in small breed normal dogs and dogs affected
with mitral valve disease. Data are expressed as mean values 6 standard deviation.
Normal SB (n 5 17) Affected SB (n 5 18) P Value
Dog weight (kg) 7.3 6 3.1 11 6 2.7 NS
Age (years) 8.7 6 3.5 11 6 3.2 ,.05
FS (%) 40.06 6 8.9 45.6 6 8.04 ,.05
EDD/EDDe 0.99 6 0.13 1.28 6 0.14 ,.001
ESD/ESDe 0.89 6 0.21 1.11 6 0.13 ,.001
ESVI (mL/m2) 21.18 6 13.90 30.0 6 2.30 ,.05
EDVI (mL/m2) 70.5 6 26.5 138.8 6 47.8 ,.05
LA/Ao 1.22 6 0.31 2.24 6 0.31 ,.001
h (cm) 0.71 6 0.04 0.74 6 0.18 NS
R (cm) 1.14 6 0.24 1.85 6 0.41 ,.001
h/R 0.53 6 0.11 0.41 6 0.12 ,.05
SB, small breed; NS, not significant; SBP, systolic blood pressure; FS, fractional shortening; EDD, end diastolic diameter; ESD, end
systolic diameter; EDDe, expected end diastolic diameter; ESDe, expected end systolic diameter; ESVI, end-systolic volume index; EDVI,
end diastolic volume index; LA/Ao, left atrium aortic root ratio; h/R, left ventricular free wall thickness/left ventricle diastolic radius ratio.
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manifest more evident systolic dysfunction. FS and EF
are influenced by different factors such as preload,
afterload, contractility and heart rate, whereas ESVI is
considered to be primarily influenced by contractility,
and afterload. Because EDVI is an indicator of preload,
we can assume there were no differences in preload
among groups. On the other hand, SB dogs have a higher
mean SBP value, which should lead to a decrease in FS.
To the contrary, FS was higher in this group.
Both groups of affected dogs had significantly
increased of FS, ESVI, and EDVI compared with
normal control dogs of similar size. Increases in FS
and EDVI were not unexpected in patients with volume
overload. In fact, increased preload with a preserved or
partially preserved contractility will increase FS and
increase EDVI because of the development of eccentric
hypertrophy. Both groups had a significantly increased
mean ESD/ESDe and mean ESVI. In fact, mitral valve
insufficiency could be considered as a condition of pure
volume overload. In this condition, systolic dysfunction
is echocardiographically recognized by increased values
of ESVI, and by values of FS near the lower end of the
reference range.13,35 Because both groups had SBP within
the normal reference range, higher ESVI compared with
normal controls should indicate that both had systolic
dysfunction, and this conclusion also is supported by the
increased ESD/ESDe ratio in both groups of diseased
dogs. In fact, ESVI is estimated by the ESV indexed to
body surface area, and both of these 2 parameters are
influenced by BW. Recently, it was demonstrated that
many M-mode–derived measurements can be more
accurately predicted by using a function involving the
cubic root of the BW.11 Thus, our expected values
correct for possible differences associated with differ-
ences in BW. Some normal SB dogs have ESVI of
30 mL/m2 or slightly more, and systolic dysfunction
should not be based only on an evaluation of this
parameter. The indication of MF in SB dogs with CMVI
and moderate HF is noteworthy. Clinical signs of
congestive HF in SB may be mainly caused by the
severity of valvular regurgitation, and clinical signs of
disease may be primarily from increased pulmonary
venous pressure and pulmonary edema and less from
reduced forward cardiac output.36 Recognition of
systolic dysfunction in earlier stages of HF suggests
that systolic dysfunction may contribute to the pro-
gression of clinical signs of disease, as has been reported
in humans and dogs.1,12,15,29 However, dogs with acute
chordal rupture present with acute onset of signs
because of severe pulmonary edema and maintain
a relatively preserved systolic function. Also, all dogs
in this study had chronic moderate HF and to be
included they had to have signs for at least 3 months
and not signs of acute pulmonary edema during this
time. Several hypotheses could explain the development
of MF in dogs with mitral valve insufficiency. In
experimentally induced chronic mitral regurgitation in
dogs, the decreased number of myofibrils in cardiomyo-
cytes and decreased fractional rate of protein turnover
seem to contribute to MF, leading to an insufficient
increase in LV mass.3,4,36 The inadequate hypertrophy
that develops with CMVI could be one mechanism that
contributes to the left ventricular dysfunction observed
both in people and in experimental dogs.37 In this study,
we evaluated the degree of eccentric hypertrophy by
using the h/R ratio. In pressure overload, systolic stress
may trigger the production of new sarcomeres assembled
in parallel, thereby increasing wall thickness, whereas in
the volume overload of valvular regurgitation, an in-
crease in diastolic stress causes replication of sarcomeres
in series, thereby increasing myocyte length. This
condition leads to eccentric hypertrophy with a normal
h/R ratio.26 Eventually, this effect normalizes systolic but
not diastolic wall stress. Wall stress imposed by pure
volume overload may not be a very potent stimulus for
cardiac hypertrophy, and, in a canine experimental model
of CMVI, this condition was associated with inadequate
left ventricular hypertrophy, culminating in systolic
dysfunction.4 We observed that, in both LB and SB dogs,
posterior wall thickness was not different from normal
dogs, whereas LV radius was increased so that the h/R
ratio was decreased compared with normal dogs. These
data indicate that end-diastolic wall stress is increased in
dogs with pure volume overload and chronic moderate
HF, and agree with results of experimental studies in
dogs.38,39 With left ventricular enlargement, meridional
wall stress increases more than does circumferential wall
stress.26,40 Because LB dogs could have a contractility
pattern more oriented on the long axis, increased
meridional stress could be responsible for the more severe
systolic dysfunction observed in LB dogs with CMVI.
Study Limitation
One limitation of this study was the inability to
exclude with certainty concurrent diseases of either
a systemic or a cardiac nature that could have affected
systolic dysfunction. Although we used recommended
criteria for the diagnosis of the disease,1,2,23 other
undefined systemic or metabolic conditions (eg, malig-
nancies) could have affected myocardial function. Re-
cently, the presence of intramural arteriosclerosis and
fibrosis in the myocardium of dogs with CMVI has been
described, but the role of these findings in the
pathogenesis of the disease is unclear.e Although LB
dogs included in the study were presented with mitral
valve lesions typical of MVP and degenerative valvular
disease, some of the dogs could have another concom-
itant primary myocardial disease, such as dilated
cardiomyopathy (DCM). However, one of the inclusion
criteria to be fulfilled was a FS . 20%, and it is unlikely
that dogs with a FS . 20% and with moderate HF
would have DCM. This conclusion would support MF
as being secondary to primary mitral valve dysfunction
rather than a primary event.41
ESVI represents a global index of ventricular function
and does not represent contractility at a cellular level.
Therefore, contractility dysfunction at the cellular level
could occur before it can be detected by using an
echocardiographic index such as ESVI.
Another possible limitation of the study is that
systolic function can be affected by age.6 Affected dogs
of this study were significantly older than the normal
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dogs. However, to the knowledge of the authors, no
published study has evaluated systolic function in
normal young and aged dogs.
One of the possible factors influencing left ventricular
hypertrophy and systolic dysfunction in pure volume
overload is the duration of the disease. Affected dogs of
our study were retrospectively selected, and they had
signs of HF that had been present a variable period of
time, which may have influenced our results. However,
all dogs with CMVI were classified with class II
ISACHC HF, and all of them had clinical signs of HF
for at least 3 months. Moreover, none of them had
a history of acute decompensation within the last
month. Chronic disease also is suggested by the
increased LA/Ao root ratio of the diseased dogs.
Finally, an experimental study showed that dogs with
induced CMVI did not develop left ventricular hyper-
trophy in response to decreased contractile function, and
it is unlikely that this factor influenced our data.36
Finally, it is possible that ongoing therapy, which
may affect loading conditions, could have influenced
the results. All affected dogs in this study were treated
with an angiotensen converting enzyme inhibitor and
furosemide at standard dosages, at least for 3 months.
Therapy-induced reductions in pre- and afterload
should, theoretically, decrease the stimulus for left
ventricular hypertrophy further.42 Moreover, decreased
preload could have influenced echocardiographically
measured systolic function according to Starling’s law.
However, this effect should have been balanced by the
lower SBP found in affected dogs.
Results of our study are in agreement with the
suggested hypothesis that decreased contractile perfor-
mance may be an intrinsic property of left ventricular
volume overload induced by naturally occurring CMVI
in both SB and LB dogs, and that this decreased systolic
function could be in part because of an inadequate
degree of hypertrophy.
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Electronics, Alhoa, OR
b MEGAS, ESAOTE Biomedica, Florence, Italy
c Instat 306, GraphPad Software, Inc., SanDiego, CA
d Borgarelli M, Crosara S, Savarino P, et al. Echocardiographic
evaluation of systolic function in small and large breed dogs
Proceed. Società Italiana delle Scienze Veterinarie (SISVet),
Viareggio September 21–24 2005, 86 (abstract)
e Falk T, Jonsson L, Olsen LH, Pedersen HD Arteriosclerotic
changes in myocardium, lung and kidney in dogs with chronic
congestive heart failure and myxomatous mitral valve disease. J
Vet Int Med 2005;19:932 (abstract)
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